Home › Researcher directory › Thierry Cresteil
Thierry Cresteil
Affiliation : Université Paris-Sud · Ingénierie et Plateformes au Service de l'Innovation Thérapeutique
- 13Publications (affiliation in France)
- 216Total publications
- 8169Citations
- 49h-index
Research profile
Thierry Cresteil has 13 indexed publications (2011–2025). Their work appears mainly in “European Journal of Medicinal Chemistry”, “Molecular Pharmaceutics” and “Oncology”. Their most cited article, “Original Multivalent Copper(II)-Conjugated Phosphorus Dendrimers and Corresponding Mononuclear Copper(II) Complexes with Antitumoral Activit” (2013), has been cited 102 times. Their work is co-authored with at least 12 researchers, including institutions in Morocco, Algeria, China, Portugal.
Is this you? Get your research seen
Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.
Create my free profile Add my publicationsResearch areas
- Pharmacogenetics and Drug Metabolism
- Synthesis and biological activity
- Drug-Induced Hepatotoxicity and Protection
- Drug Transport and Resistance Mechanisms
- Metal-Catalyzed Oxygenation Mechanisms
Publications (13)
- Corrigendum to “Targeting prohibitin with small molecules unravels a common signaling pathway for melanogenesis and apoptosis in melanoma cells” [Eur. J. Med. Chem. 155 (2018) 880]
- Targeting prohibitin with small molecules to promote melanogenesis and apoptosis in melanoma cells
- First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents
- First-in-Class Anti-Cancer Nanoparticle Copper(Ii) Phosphorus Dendrimers as Pro-Apoptotic Bax Activators
- Discovery of Iminobenzimidazole Derivatives as Novel Cytotoxic Agents
- Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activators
- Original Multivalent Gold(III) and Dual Gold(III)–Copper(II) Conjugated Phosphorus Dendrimers as Potent Antitumoral and Antimicrobial Agents
- A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action
- Investigations on dendrimer space reveal solid and liquid tumor growth-inhibition by original phosphorus-based dendrimers and the corresponding monomers and dendrons with ethacrynic acid motifs
- Comparative EPR studies of Cu( ii )-conjugated phosphorous-dendrimers in the absence and presence of normal and cancer cells
- Antiangiogenic activity of neutral lipids, glycolipids, and phospholipids fractions of Pinus halepensis Mill. seeds
- Original Multivalent Copper(II)-Conjugated Phosphorus Dendrimers and Corresponding Mononuclear Copper(II) Complexes with Antitumoral Activities
- Synthesis and Anti-Proliferative Activity of Novel Quinolin-8-ol Derivatives
Publication venues
- European Journal of Medicinal Chemistry × 4
- Molecular Pharmaceutics × 2
- Oncology × 1
- The Open Medicinal Chemistry Journal × 1
- Nanoscale × 1
- RSC Advances × 1
Publications per year
- 20251
- 20184
- 20172
- 20161
- 20143
- 20131
- 20111
Collaborations
Partner institutions : Centre National de la Recherche Scientifique · Laboratoire de Chimie de Coordination · Université de Strasbourg · Université Toulouse III - Paul Sabatier · Institut National Polytechnique de Toulouse
Co-authors’ countries : Morocco · Algeria · China · Portugal
Co-authors
- Serge M. Mignani
- Jean‐Pierre Majoral
- Anne‐Marie Caminade
- Nabil El Brahmi
- Hassan Hammoud
- Laurent Désaubry
- Embarek Bentouhami
- Régis Laurent
- Joachim Caron
- Canan G. Nebigil
- Geneviève Aubert
- Laure Eloy
Bibliographic data from OpenAlex (open database).
Why choose Dzcademia?
Profiles, articles and conference contributions: give your research a structured public presence. Integrated metadata help search engines and AI assistants identify your work and understand its references.
Comment with Google
Sign in with Google to comment directly on this page.